Sun Pharma Q2 net falls 46.5% on Protonix provision

Sun Pharmaceutical Industries reported a 46.5 percent drop in quarterly net profit after it set aside Rs 5.84 billion towards a possible compensation in a patent dispute case related to drug Protonix.

The Mumbai-based drugmaker said consolidated net profit fell to Rs 3.2 billion during fiscal second quarter ended September from Rs 5.98 billion a year earlier. Net sales rose 40.2 percent to Rs 26.57 billion.

Analysts had estimated the net profit at Rs 7.68 billion, according to Thomson Reuters I/B/E/S.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Digging up carcasses from excavation sites is not going to take this nation forward

    The Bharat Ratna, bestowed by the world’s largest democracy as its highest civilian honour, “in recognition of exceptional service/performance of

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: THE EMPATHY GAP

The empathy gap (also known as the hot-cold empathy gap) ...

Zehra Naqvi

A thrilling journey

Amrita Chowdhury could well be India’s Jeffery Archer. Edge-of-the-seat thriller ...

Bubbles Sabharwal

Time to gift ourselves some good cheer

The other day, my labrador Cesar asked me, “You do ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture